(Q34303431)

1 August 2017

1 reference

title

Do beta-tubulin mutations have a role in resistance to chemotherapy? (English)

1 reference

1 August 2017

1 reference

Helen K Berrieman

1

1 reference

1 August 2017

Michael J Lind

series ordinal

2

1 reference

1 August 2017

Lynn Cawkwell

series ordinal

3

1 reference

1 August 2017

publication date

1 March 2004

1 reference

Lancet Oncology Commission

1 August 2017

published in

1 reference

1 August 2017

volume

5

1 reference

1 August 2017

issue

3

1 reference

1 August 2017

page(s)

158-164

1 reference

Structural insight into microtubule function

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901411-1

7 January 2021

Molecular effects of paclitaxel: myths and reality (a critical review).

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901411-1

7 January 2021

Mechanisms of action of and resistance to antitubulin agents: microtubule dynamics, drug transport, and cell death

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901411-1

7 January 2021

Characterization of the taxol binding site on the microtubule. 2-(m-Azidobenzoyl)taxol photolabels a peptide (amino acids 217-231) of beta-tubulin

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901411-1

7 January 2021

Characterization of the Taxol Binding Site on the Microtubule

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901411-1

7 January 2021

Structure of the alpha beta tubulin dimer by electron crystallography

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901411-1

7 January 2021

Refined structure of alpha beta-tubulin at 3.5 A resolution

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901411-1

7 January 2021

Localization of the vinblastine-binding site on beta-tubulin.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901411-1

7 January 2021

Identification of conserved isotype-defining variable region sequences for four vertebrate beta tubulin polypeptide classes

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901411-1

7 January 2021

Evolutionary history of a multigene family: an expressed human beta-tubulin gene and three processed pseudogenes

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901411-1

7 January 2021

Genetic analysis of the beta-tubulin gene, TUBB, in non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901411-1

7 January 2021

Mutational analysis of the class I beta-tubulin gene in human breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901411-1

7 January 2021

Diverse Mechanisms in the Generation of Human β-Tubulin Pseudogenes

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901411-1

7 January 2021

Evidence that a human beta-tubulin pseudogene is derived from its corresponding mRNA.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901411-1

7 January 2021

Mutational analysis of the beta-tubulin gene in lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901411-1

7 January 2021

Antisense oligonucleotides to class III beta-tubulin sensitize drug-resistant cells to Taxol

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901411-1

7 January 2021

Altered beta-tubulin isotype expression in paclitaxel-resistant human prostate carcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901411-1

7 January 2021

Taxol-resistant epithelial ovarian tumors are associated with altered expression of specific beta-tubulin isotypes

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901411-1

7 January 2021

Cloning and sequencing of human betaIII-tubulin cDNA: induction of betaIII isotype in human prostate carcinoma cells by acute exposure to antimicrotubule agents

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901411-1

7 January 2021

Paclitaxel-resistant human ovarian cancer cells have mutant beta-tubulins that exhibit impaired paclitaxel-driven polymerization

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901411-1

7 January 2021

A common pharmacophore for epothilone and taxanes: molecular basis for drug resistance conferred by tubulin mutations in human cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901411-1

7 January 2021

High-resolution model of the microtubule

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901411-1

7 January 2021

Identification of a p53 response element in the promoter region of the hMSH2 gene required for expression in A2780 ovarian cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901411-1

7 January 2021

Paclitaxel resistance in non-small-cell lung cancer associated with beta-tubulin gene mutations

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901411-1

7 January 2021

Lack of beta-tubulin gene mutations in early stage lung cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901411-1

7 January 2021

New insights in beta-tubulin sequence analysis in non-small cell lung cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901411-1

7 January 2021

Re: Genetic analysis of the beta-tubulin gene, TUBB, in non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901411-1

7 January 2021

Re: genetic analysis of the beta-tubulin gene, TUBB, in non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901411-1

7 January 2021

10.1016/S1470-2045(04)01411-1

Identifiers

DOI

1 reference

1 August 2017

1 reference